Epithelial Ovarian

Oncology

14 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Phase 3(3)

Phase 2(3)

Drug	Company
Mirvetuximab Soravtansine	AbbVie Inc. (ABBV)
pegfilgrastim	Bolt Biotherapeutics, Inc. (BOLT)
torl-1-23	Bolt Biotherapeutics, Inc. (BOLT)

Phase 1(3)

Phase 1/Phase 2(2)

Drug	Company
imnn-001	Imunon, Inc. (IMNN)
skb264	CHINA PHARMA HOLDINGS, INC. (CPHI)

BioSniper tracks 14 drugs in development for Epithelial Ovarian across 11 companies.

There are 1 clinical trial targeting Epithelial Ovarian tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.